Live from #AACR26: Dr. Antoni Ribas of @UCLA highlighted new strategies to overcome immunotherapy resistance in melanoma, including combination and CAR T approaches aimed at addressing tumor heterogeneity and relapse. #AACR26 https://t.co/svLU59id0r